ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 38 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 42.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $170,000 | -22.4% | 343,720 | +41.0% | 0.05% | -19.3% |
Q1 2022 | $219,000 | -73.3% | 243,720 | -66.7% | 0.06% | -72.3% |
Q4 2021 | $820,000 | -37.1% | 732,500 | 0.0% | 0.21% | -40.5% |
Q3 2021 | $1,304,000 | -41.7% | 732,500 | +8.1% | 0.35% | -26.1% |
Q2 2021 | $2,236,000 | -1.5% | 677,500 | 0.0% | 0.47% | -13.2% |
Q1 2021 | $2,270,000 | +1284.1% | 677,500 | +687.0% | 0.54% | +917.0% |
Q3 2020 | $164,000 | -4.7% | 86,082 | 0.0% | 0.05% | +6.0% |
Q2 2020 | $172,000 | +95.5% | 86,082 | 0.0% | 0.05% | +35.1% |
Q1 2020 | $88,000 | -63.2% | 86,082 | -26.9% | 0.04% | -54.9% |
Q4 2019 | $239,000 | – | 117,682 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |